Bladder cancer originates from the cells lining the inner surface of the bladder and is one of the oncologic diseases commonly encountered in urology. The disease can remain limited at an early stage, but in some cases it can spread into the deeper layers of the bladder wall or surrounding tissue.
Blood in the urine, burning during urination, frequent urination and a sudden urge to urinate are among the most common symptoms of bladder cancer. Since these symptoms can also occur in other conditions, a detailed evaluation is needed for a definitive diagnosis.
Urine tests, imaging methods and endoscopic examination (cystoscopy) are the primary tools for diagnosing bladder cancer. When necessary, tissue samples taken are pathologically examined to determine the type and grade of the cancer.
Based on the findings, the disease's stage and extent are clarified. This assessment ensures the treatment plan is built correctly.
Treatment of bladder cancers is planned according to the disease's stage, the tumor's characteristics and the patient's general health. Intravesical treatments and surgical procedures may be the priority for early-stage patients, while more comprehensive treatment approaches may be considered for advanced stages.
The main goal of the treatment process is to control the disease, reduce the risk of recurrence and preserve bladder function as much as possible. The treatment plan is determined through individual evaluation.
Since bladder cancers are among the diseases that can carry a risk of recurrence, regular follow-up is very important. The course of the disease is closely monitored through endoscopic check-ups, imaging tests and clinical evaluations.
This follow-up process helps detect possible recurrences early and contributes to healthy long-term results.
